Bladder Cancer - Results from #320

TROP2 Expression Across Molecular Subtypes of Urothelial Carcinoma and Enfortumab Vedotin-resistant Cells. February 28, 2022

Outcomes by time to definitive chemoradiation treatment for patients with muscle-invasive bladder cancer. February 28, 2022

Oncologic impact of concomitant prostate cancer characteristics at the time of radical cystoprostatectomy for bladder cancer: a population-based analysis. February 25, 2022

A clinical study of a CD44v6-targeted fluorescent agent for the detection of non-muscle invasive bladder cancer. February 25, 2022

Holmium laser-assisted laparoscopic partial cystectomy for bladder cancer: a single-institutional pilot study with technical feasibility and short-term oncological outcome. February 24, 2022

Development and Validation of a Prognostic Nomogram for Predicting Cancer-Specific Survival in Patients With Lymph Node Positive Bladder Cancer: A Study Based on SEER Database. February 24, 2022

Baseline Health-related Quality of Life Predicts Bladder Cancer-specific Survival Following Radical Cystectomy. February 23, 2022

Dietary fats and their sources in association with the risk of bladder cancer: a pooled analysis of 11 prospective cohort studies. February 23, 2022

Characterization of Cellular and Acellular Analytes from Pre-Cystectomy Liquid Biopsies in Patients Newly Diagnosed with Primary Bladder Cancer. February 22, 2022

Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancer. February 22, 2022

Diagnostic accuracy of vesical imaging-reporting and data system (VI-RADS) for the detection of muscle-invasive bladder cancer: a meta-analysis. February 22, 2022

Carboplatin-based adjuvant chemotherapy versus observation after radical cystectomy in patients with pN1-3 urothelial bladder cancer. February 21, 2022

The Role of New Technologies in the Diagnosis and Surveillance of Non-Muscle Invasive Bladder Carcinoma: A Prospective, Double-Blinded, Monocentric Study of the XPERT© Bladder Cancer Monitor and Narrow Band Imaging© Cystoscopy. February 21, 2022

Incidence of bladder cancer in neuro-urological patients in France: a nationwide study. February 21, 2022

Long term cost comparisons of radical cystectomy versus trimodal therapy for muscle-invasive bladder cancer. February 18, 2022

Cruciferous Vegetable Intervention to Reduce the Risk of Cancer Recurrence in Non-Muscle-Invasive Bladder Cancer Survivors: Development Using a Systematic Process. February 18, 2022

Prognostic Impact of CD36 Immunohistochemical Expression in Patients with Muscle-Invasive Bladder Cancer Treated with Cystectomy and Adjuvant Chemotherapy. February 17, 2022

Associations between Dietary Patterns and Malnutrition, Low Muscle Mass and Sarcopenia in Adults with Cancer: A Scoping Review. February 17, 2022

A Comprehensive Approach to Clinical Staging of Bladder Cancer. February 17, 2022

The Accuracy of Transurethral Bladder Resection in Detecting Bladder Cancer Histological Variants and Their Prognostic Value at Radical Cystectomy. February 17, 2022

Page 17 of 436

email news signup